as of Sep 2
KVUE
DefensiveKENVUE INC.
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements.
Close · 3M
+8.35%
Held by 2 AI ETFs
as of Sep 1
Signal performance
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
LQAI · Weight increase · 2d
weight 1.690% → 1.770% (+0.080 pp)·stock down 2.1% in the 30 days before
Sep 2·entry $19.13·now $18.95Fresh
LQAI · Weight decrease · 3d
weight 1.750% → 1.710% (-0.040 pp)·stock down 3.0% in the 30 days before
Aug 27·entry $19.20·now $18.95
LQAI · Weight decrease · 2d
weight 1.750% → 1.720% (-0.030 pp)·stock down 2.7% in the 30 days before
Aug 26·entry $19.22·now $18.95
LQAI · Weight increase · 2d
weight 1.680% → 1.750% (+0.070 pp)·stock up 0.8% in the 30 days before
Aug 24·entry $19.43·now $18.95Fresh
LQAI · Weight increase · 2d
weight 1.630% → 1.700% (+0.070 pp)·stock up 0.6% in the 30 days before
Aug 19·entry $19.13·now $18.95Fresh
LQAI · Weight decrease · 4d
weight 1.710% → 1.630% (-0.080 pp)·stock down 1.0% in the 30 days before
Aug 17·entry $18.79·now $18.95
LQAI · Weight decrease · 3d
weight 1.710% → 1.660% (-0.050 pp)·stock up 0.9% in the 30 days before
Aug 14·entry $19.20·now $18.95
LQAI · Weight decrease · 2d
weight 1.710% → 1.680% (-0.030 pp)·stock up 2.7% in the 30 days before
Aug 13·entry $19.20·now $18.95
LQAI · Weight decrease · 2d
weight 1.730% → 1.710% (-0.020 pp)·stock down 2.3% in the 30 days before
Aug 10·entry $19.03·now $18.95
LQAI · Weight decrease · 3d
weight 1.790% → 1.640% (-0.150 pp)·stock down 4.1% in the 30 days before
Aug 3·entry $19.01·now $18.95
LQAI · Weight decrease · 2d
weight 1.790% → 1.680% (-0.110 pp)·stock down 0.5% in the 30 days before
Jul 31·entry $19.24·now $18.95
LQAI · Weight increase · 3d
weight 1.620% → 1.790% (+0.170 pp)·stock up 3.8% in the 30 days before
Jul 29·entry $19.79·now $18.95Fresh
LQAI · Weight increase · 2d
weight 1.620% → 1.740% (+0.120 pp)·stock up 3.2% in the 30 days before
Jul 28·entry $19.75·now $18.95Fresh
LQAI · Weight increase · 3d
weight 1.580% → 1.650% (+0.070 pp)·stock up 3.0% in the 30 days before
Jul 17·entry $18.98·now $18.95Fresh
LQAI · Weight increase · 2d
weight 1.580% → 1.630% (+0.050 pp)·stock up 4.2% in the 30 days before
Jul 16·entry $19.02·now $18.95Fresh
LQAI · Weight decrease · 4d
weight 2.040% → 1.610% (-0.430 pp)·stock up 9.3% in the 30 days before
Jul 9·entry $19.18·now $18.95
LQAI · Weight decrease · 3d
weight 2.040% → 1.640% (-0.400 pp)·stock up 8.9% in the 30 days before
Jul 8·entry $19.29·now $18.95
LQAI · Weight decrease · 2d
weight 2.040% → 1.680% (-0.360 pp)·stock up 17.2% in the 30 days before
Jul 7·entry $19.78·now $18.95
LQAI · Weight increase · 2d
weight 1.890% → 2.040% (+0.150 pp)·stock up 14.5% in the 30 days before
Jul 2·entry $19.83·now $18.95Fresh
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.
Buffett-style framework
AIEQ recently made a new entry into Kenvue, indicating a positive signal from that AI, while LQAI showed a recent trend of decreasing its weight after a slight increase. This mixed AI sentiment contrasts with the framework's overall 'Fail' verdict, which is primarily driven by the inability to confirm critical financial health metrics and valuation.
- Circle of CompetenceKenvue's position in consumer staples with established brands suggests predictable unit economics suitable for long-term cash flow projections.
- Economic MoatThe company benefits from strong brand power and established market positions for its consumer health products, creating durable competitive advantages.
- ManagementSpecific information regarding management's candor, capital allocation discipline, or ownership stake is not provided.
- Financial HealthInsufficient financial data, including 10-year ROE trend, operating margins, debt profile, and owner earnings, prevents a comprehensive assessment of financial health.
- Margin of SafetyWithout an intrinsic value estimate, it is not possible to determine if the current price offers a margin of safety.
Kenvue, a consumer staples company with strong brands, passes the circle of competence and economic moat stages. However, a comprehensive assessment of its financial health, management quality, and intrinsic value is hindered by insufficient public data for several key criteria, leading to an overall 'Fail' verdict within this framework.
Educational interpretation generated by AI applying frameworks Warren Buffett documented in his shareholder letters and other public writings. Not a statement by Mr. Buffett or Berkshire Hathaway, and not investment advice.